Cargando...
Targeted Therapy in Biliary Tract Cancers
A paradigm shift towards molecular-based, personalized cancer therapeutics has occurred in recent years and a number of targeted drugs have emerged. Various targeted therapies like erlotinib, trastuzumab, and cetuximab have been approved in lung, breast, and colon cancers, respectively. Numerous cli...
Gardado en:
| Publicado en: | Curr Treat Options Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4534500/ https://ncbi.nlm.nih.gov/pubmed/26266637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-015-0366-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|